| Osteosarcoma altered in cohorts of …ALTERED_INderived97 of 97show fewer |
|---|
| ← altered in cohorts of | TP53 70 / 145 cases (48 %) · ssm · TARGET-OS · largest of 2 cohorts | — | — | Osteosarcoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXO3B 68 / 145 cases (47 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBC1D28 68 / 145 cases (47 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIM16L 68 / 145 cases (47 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDRT4 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EVPLL 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM83G 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXW10 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FLII 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GRAP 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LGALS9C 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MIEF2 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRPSAP2 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHMT1 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC5A10 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMCR8 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TOP3A 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TVP23B 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TVP23C 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TVP23C-CDRT4 67 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADORA2B 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ALDH3A1 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ALKBH5 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | B9D1 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDRT1 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DRG2 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPN2 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GID4 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GRAPL 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HS3ST3B1 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LGALS9B 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LLGL1 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAP2K3 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAPK7 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MFAP4 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTSS1 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYO15A 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCOR1 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF112 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC47A1 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TATDN1 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBC1D26 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIM16 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRPV2 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTC19 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF286A 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSWIM7 66 / 145 cases (46 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AKAP10 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ALDH3A2 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATPAF2 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDRT15 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDRT15L2 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CENPV 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COX10 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSMD3 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAH9 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DRC3 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FER1L6 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNJ12 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MED9 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTRNR2L1 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYC 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NDUFB9 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NT5M 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIGL 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLD6 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PMP22 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POU5F1B 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RASD1 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF139 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC47A2 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPECC1 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TEKT3 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM65 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRMT12 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBB 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ULK2 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASAP1 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATAD2 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC144A 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CPQ 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DERL1 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DHRS7B 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM91A1 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FLCN 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HS3ST3A1 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MPRIP 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NATD1 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NSMCE2 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NTAQ1 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SDC2 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM11 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TOM1L2 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIB1 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP22 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WASHC5 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF572 64 / 145 cases (44 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |